Polymorphs prediction

Abraham, N.L. and Probert, N.J., A periodic genetic algorithm with real space representation for crystal structure and polymorph prediction, Phys. Rev. B., 73, 224106,2006. [Pg.171]

Klausen IC, Gerdes LU, Meinertz H, Hansen FA, Faergeman O. Apolipopro-tein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration. Eur J Clin Invest 1993 23 240-245. [Pg.280]

Algorithm with Real-Space Representation for Crystal Structure and Polymorph Prediction. [Pg.387]

Han, J. Y., Lim, H. S., Shin, E. S., et al. (2006) Comprehensive analysis of UGTIA polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-ceU lung cancer treated with irinotecan and cisplatin. J. Clin. Oncol. 24, 2237-2244. [Pg.412]

Ames, S., Ellis, K., Gurm, S., Copeland, K., and Abrams, S. (1999). Vitamin D receptor gene Fokl polymorphism predicts calcium absorption and bone mineral density in children. JBMR 14, 740-746. [Pg.329]

Carlini EE, Meropol NJ, Bever J et al. UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res 2005 11 1226-1236. [Pg.170]

Carlotti E, Palumbo GA, Oldani E et al. Bone marrow BCL2/IgH+ cells at diagnosis and not FC-GRIIIA polymorphism predict response in follicular non-Hodgkin s lymphoma patients treated with sequential CHOP and rituximab. Blood 2005 106 289-290a. [Pg.228]

Han JY, Lim HS, Shin ES et al. Comprehensive analysis of UGTIA polymorphisms predictive for pharmaeokineties and treatment outeome in patients with non-small-cell lung cancer treated with irinoteean and eisplatin. J Clin Oncol 2006 24 2237-2244. [Pg.368]

Stoehlmacher J, Park DJ, Zhang W et al. A multivariate analysis of genomic polymorphisms prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal... [Pg.368]

Park DJ, Stoehlmacher J, Zhang W et al. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res 2001 61 8654-8658. [Pg.368]

Zhou W, Gurubhagavatula S, Liu G et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004 10 4939 943. [Pg.369]

Quintela-Fandino M, Hitt R, Medina PP et al. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Ch Oncol 2006 24 4333 339. [Pg.369]

Mannucci PM, Mari D, Merati G, Peyvandi F, Tagliabue L, Sacchi E, Taioli E, Sansoni P, Bertolini S, Franceschi C. Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vase Biol 1997 17 755-759. [Pg.207]

Masuo K, Katsuya T, Sugimoto K, Kawaguchi H, Rakugi H, Ogihara T, Tuck ML. High plasma norepinephrine levels associated with 32-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertens. Res. 2007 30 503-511. [Pg.77]

Their software platform is open, component-based, and works with commonly used systems such as Windows, Linux, UNIX, and Oracle databases. The drug discovery product offerings cover an expansive array of topics from basic lead optimization to Lipinski factors and polymorph predictions. The Drug Discovery/ Bioinformatics platforms address problems product confronted by pharmaceutical and biotech researchers in various fields. Product offering includes ... [Pg.54]

Another approach (common to many strategies of structure generation and polymorph prediction ) is to attempt to match the powder diffraction pattern calculated from the generated trial structure with an experimental one, although this can no longer be justified as a truly predictive procedure. [Pg.183]

How well do these methods work individually and collectively In 1999 the CCDC conducted a blind test of structure (including polymorph) prediction, in which most of the groups mentioned in this section participated (Lommerse et al. 2000). Such tests should serve as a challenge, a model and a landmark for the development of these computational techniques. [Pg.186]

The first step of a polymorphic prediction sequence is a systematic simulated annealing search through all of the defined space groups for potential structures. [Pg.29]

A986S, R990G. Common polymorphisms Predictive of serum Ca21 [39-59]... [Pg.158]

Seo BG, Kwon HC, Oh SY et al (2009) Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIBI. Oncol Rep 22 127-136... [Pg.321]

Bertolino A, Caforio G, Blasi G, Rampino A, Nardini M, Weinberger DR et al (2007) COMT Vall58Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophr Res 95(l-3) 253-255... [Pg.583]

Seitz M, Wirthmuller U, Moller B, Villiger PM (2007) The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxf) 46 93-96... [Pg.657]

Ongaro A, De Mattei M, Pellati A, Caruso A, Ferretti S, Masieri FF et al (2008) Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFalpha therapy in rheumatoid arthritis Rheumatol Int 28 901-908... [Pg.658]

Jancic I, Arsenovic-Ranin N, Sefik-Bukilica M, Zivojinovic S, Damjanov N, Spasovski V et al (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33 1481-1486... [Pg.659]

Fabris M, Quartuccio L, Lombardi S, Saracco M, Atzeni F, Carletto A (2012) The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. Autoimmun Rev 11 315-320... [Pg.660]

Qureshi AM, Herd RJ, Blake GM et al (2002) COLIA1 Spl polymorphism predicts response... [Pg.670]

Stein MB, Seedat S, Gelernter J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psy chopharmacol 2006 187 68-72. [Pg.156]

J. A. Millar, K. Thai, and J. W. Scholey, Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 56 2173-2180 (1999). [Pg.755]

Ab initio Crystal Structure Solution from XRPD Patterns and Polymorph Prediction... [Pg.45]

CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 59, 3908-3910. [Pg.520]

Liljedahl U, Kahan T, Malmqvist K, et al. (2005). Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment. [Pg.1486]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...